Joseph Alvarnas

1.9k total citations
31 papers, 880 citations indexed

About

Joseph Alvarnas is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Joseph Alvarnas has authored 31 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 9 papers in Hematology. Recurrent topics in Joseph Alvarnas's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (6 papers). Joseph Alvarnas is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (6 papers). Joseph Alvarnas collaborates with scholars based in United States. Joseph Alvarnas's co-authors include Stephen J. Forman, John A. Zaia, Amrita Krishnan, Robert S. Negrin, Yeh Ching Linn, Neil Kogut, Joycelynne Palmer, David DiGiusto, David S. Hsu and Haitang Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

Joseph Alvarnas

30 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph Alvarnas United States	12	342	270	175	174	158	31	880
A Zander Germany	17	420 1.2×	317 1.2×	102 0.6×	465 2.7×	95 0.6×	51	1.1k
AM Levine United States	15	339 1.0×	229 0.8×	34 0.2×	290 1.7×	297 1.9×	22	893
Hua-Ling Tsai United States	20	334 1.0×	252 0.9×	32 0.2×	446 2.6×	108 0.7×	41	1.2k
Anna Mozos Spain	15	182 0.5×	292 1.1×	92 0.5×	36 0.2×	196 1.2×	37	795
I L Wolvers-Tettero Netherlands	16	234 0.7×	157 0.6×	66 0.4×	277 1.6×	320 2.0×	22	1.0k
DT Scadden United States	10	170 0.5×	137 0.5×	203 1.2×	337 1.9×	88 0.6×	18	814
RK Brynes United States	19	451 1.3×	119 0.4×	60 0.3×	324 1.9×	555 3.5×	37	1.2k
Neil C. Josephson United States	19	398 1.2×	570 2.1×	42 0.2×	629 3.6×	254 1.6×	48	1.5k
M. Qasim Ansari United States	15	257 0.8×	122 0.5×	25 0.1×	123 0.7×	197 1.2×	27	698
Joseph Tripodi United States	16	64 0.2×	298 1.1×	103 0.6×	225 1.3×	33 0.2×	39	798

Countries citing papers authored by Joseph Alvarnas

Since Specialization

Citations

This map shows the geographic impact of Joseph Alvarnas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Alvarnas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Alvarnas more than expected).

Fields of papers citing papers by Joseph Alvarnas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Alvarnas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Alvarnas. The network helps show where Joseph Alvarnas may publish in the future.

Co-authorship network of co-authors of Joseph Alvarnas

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Alvarnas. A scholar is included among the top collaborators of Joseph Alvarnas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Alvarnas. Joseph Alvarnas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aribi, Ahmed, Lihua E. Budde, Joseph Alvarnas, et al.. (2022). Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient. Blood. 140(Supplement 1). 7597–7598. 1 indexed citations

Zachariah, Finly, Linda Klein, Matthew Loscalzo, et al.. (2017). The effects of global and targeted advance care planning efforts at a national comprehensive cancer center.. Journal of Clinical Oncology. 35(5_suppl). 79–79. 2 indexed citations

Zachariah, Finly, Leslie Popplewell, Stephen J. Forman, et al.. (2017). The advance directive completion rates in the hematopoietic stem cell transplant population in a major transplant cancer center.. Journal of Clinical Oncology. 35(31_suppl). 16–16.

Aldoss, Ibrahim, Ni‐Chun Tsai, Marilyn L. Slovak, et al.. (2016). Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(7). 1212–1217. 8 indexed citations

Wolfson, Julie, Steven T. Rosen, Robert B. Diasio, et al.. (2016). Value, Access, and Cost of Cancer Care Delivery at Academic Cancer Centers. Journal of the National Comprehensive Cancer Network. 14(7). 837–847. 27 indexed citations

Alvarnas, Joseph, Jennifer Le Rademacher, Richard F. Little, et al.. (2014). Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) Trial. Blood. 124(21). 674–674. 2 indexed citations

Nakamura, Ryotaro, Joycelynne Palmer, Margaret O’Donnell, et al.. (2012). Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. Leukemia Research. 36(9). 1152–1156. 25 indexed citations

Brown, Patrick A. & Joseph Alvarnas. (2012). Reaping the Benefits of Recent Advances for Adults With Acute Lymphoblastic Leukemia. Journal of the National Comprehensive Cancer Network. 10(7). 800–801. 2 indexed citations

González, Nancy, et al.. (2011). Implementation of a configurable laboratory information management system for use in cellular process development and manufacturing. Cytotherapy. 14(1). 114–121. 5 indexed citations

10.

Stein, Anthony S., Margaret O’Donnell, Timothy W. Synold, et al.. (2010). Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia. Bone Marrow Transplantation. 46(9). 1256–1262. 3 indexed citations

11.

Krishnan, Amrita, Joycelynne Palmer, John A. Zaia, et al.. (2010). HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL). Biology of Blood and Marrow Transplantation. 16(9). 1302–1308. 40 indexed citations

12.

Laport, Ginna G., Joseph Alvarnas, Joycelynne Palmer, et al.. (2008). Long-term remission of Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation–etoposide regimen. Blood. 112(3). 903–909. 77 indexed citations

13.

Krishnan, Amrita, Auayporn Nademanee, Henry C. Fung, et al.. (2006). Does Follicularity in Large Cell Lymphoma Predict Outcome after Autologous Stem Cell Transplantation?. Biology of Blood and Marrow Transplantation. 12(6). 641–647. 8 indexed citations

14.

Margolin, Kim, James H. Doroshow, Paul Frankel, et al.. (2005). Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapsed Germ Cell Cancer. Biology of Blood and Marrow Transplantation. 11(11). 903–911. 17 indexed citations

15.

Krishnan, Amrita, Arturo Molina, John A. Zaia, et al.. (2004). Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 105(2). 874–878. 119 indexed citations

16.

Alvarnas, Joseph & Stephen J. Forman. (2004). Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled.. PubMed. 18(7). 867–76; discussion 876. 19 indexed citations

17.

Somlo, George, Paul Frankel, Warren Chow, et al.. (2004). Prognostic Indicators and Survival in Patients With Stage IIIB Inflammatory Breast Carcinoma After Dose-Intense Chemotherapy. Journal of Clinical Oncology. 22(10). 1839–1848. 41 indexed citations

18.

Morgan, R.J., L. Leong, J R Schriber, et al.. (2001). Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Bone Marrow Transplantation. 28(9). 859–863. 6 indexed citations

19.

Alvarnas, Joseph, et al.. (2001). Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 7(4). 216–222. 74 indexed citations

20.

Alvarnas, Joseph, Robert S. Negrin, Sandra J. Horning, et al.. (2000). High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation. 6(3). 352–358. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact